Hydrophobic Interaction Chromatography Market Size & Share, by Products & Services (Resin, Columns, Buffer, Services); Sample (Monoclonal Antibodies, Vaccines); End-user (Pharmaceutical Companies, CROs & CMOs, Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 5000
  • Published Date: Jun 02, 2023
  • Report Format: PDF, PPT

Companies Dominating the Global Hydrophobic Interaction Chromatography Landscape

    • Sunresin New Materials Co., Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific
    • The General Electric Company
    • Sartorius AG
    • Tosoh Bioscience, Inc.
    • Sepax Technologies, Inc.
    • Merck KGaA.
    • JNC Corporation
    • Geno Technology Inc.

Browse Key Market Insights with Data Illustration:


In The News

  • Sunresin Materials Co., Ltd. announced the launch of highly cross-linked agarose chromatography, SP Seplife FF chromatography resin. It is resin with high chemical stability, low back pressure, and high dynamic loading.
  • Bio-Rad Laboratories, Inc. launched its new CHT prepacked Foresight ProColumns. It is intended to facilitate downstream process-scale chromatography operations at various phases of biological drug research and manufacturing.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5000
  • Published Date: Jun 02, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising development of vaccines and higher investment in biopharma industries are the major factors driving the market growth.

The market size of hydrophobic interaction chromatography is anticipated to attain a CAGR of 10.5% over the forecast period, i.e., 2023 – 2035.

: The major players in the market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, The General Electric Company, Sartorius AG, Tosoh Bioscience Inc., Sepax Technologies, Inc., Merck KGaA., JNC Corporation, and Geno Technology Inc., and Sunresin New Materials Co.Ltd.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by sample, product & services, end user, and by region.

The monoclonal antibodies segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Lack of trainer forces, and high cost of implementation are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying